glp-1 agonist. receptor agonists show promise in treating substance use disorders Discovery of GLP-1–Based Drugs for

In recent years, research has shown that GLP-1s may help with a variety of conditions, including obstructive sleep apnea, heart disease, and chronic kidney disease

The tapering protocol: step by step If you and your provider decide that discontinuation is the goal, doing it right dramatically improves your chances of maintaining results

Exposure to glucagon-like peptide 1 receptor agonists does not increase the risk of AKI associated with anticancer therapy: FR-OR80

To assess heterogeneity, Chi-square and I 2 statistics were utilized, with significant heterogeneity defined as a p -value below 0.1 and an I 2 exceeding 50%

Smaller meals, less greasy food, and slower eating also help